← Open Payments lookup

KENZIE SIMS: Open Payments

NPI 1043974678 · NATCHEZ, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$784 in 41 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $502 · 2025 $784

Food & beverage: $784
CompanyPaymentsAmount
ABBVIE INC.21$375
AstraZeneca Pharmaceuticals LP5$86
Boehringer Ingelheim Pharmaceuticals, Inc.3$58
Astellas Pharma US Inc2$47
Novo Nordisk Inc2$46
Sumitomo Pharma America, Inc.2$39
GlaxoSmithKline, LLC.2$38
Exact Sciences Corporation1$27
Takeda Pharmaceuticals U.S.A., Inc.1$25
Ardelyx, Inc.1$21

Products named: QULIPTA, CREON, LINZESS, JARDIANCE, BREZTRI, Veozah, GEMTESA, TRELEGY ELLIPTA.

Industry payments across MS — which companies pay providers there.